Nivolumab With SBRT vs Nivolumab Alone in Metastatic HNSCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
J. Clin. Oncol 2020 Aug 21;[EPub Ahead of Print], S McBride, E Sherman, CJ Tsai, S Baxi, J Aghalar, J Eng, WI Zhi, D McFarland, LS Michel, R Young, R Lefkowitz, D Spielsinger, Z Zhang, J Flynn, L Dunn, A Ho, N Riaz, D Pfister, N LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.